- Draft legislation
This is a draft item of legislation. This draft has since been made as a UK Statutory Instrument: The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025 No. 538
Part 4 Amendment to Part 3 (Authorisation for Clinical Trials and Ethics Committee Opinion)
Part 5 Amendment to Part 4 (Good Clinical Practice and the Conduct of Clinical Trials)
Part 7 Amendment to Part 6 (Manufacture and Importation of Investigational Medicinal Products)
Part 8 Insertion of new Part 6A (Non-Investigational Medicinal and Non-Medicinal Products)
Part 9 Substitution of Part 7 (Labelling of Investigational Medicinal Products)
Part 10 Amendment to Part 8 (Enforcement and Related Provisions)
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Draft Explanatory Memorandum sets out a brief statement of the purpose of a Draft Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Draft Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including:
The data on this page is available in the alternative data formats listed: